Childhood-onset primary Sjögren's syndrome in a tertiary center in China: Clinical features and outcome
Yinv Gong,Haimei Liu,Guomin Li,Tao Zhang,Yifan Li,Wanzhen Guan,Qiaoqian Zeng,Qianying Lv,Xiaomei Zhang,Wen Yao,Yu Shi,Hong Xu,Li Sun
DOI: https://doi.org/10.21203/rs.3.rs-1940626/v1
2022-01-01
Abstract:AbstractObjectives To characterize clinical features and outcome of childhood-onset primary Sjögren’s syndrome (pSS). Methods Patients less than 18 years-old, fulfilling the 2002 the American-European Consensus Group (ACEG) criteria or 2016 the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria for pSS, or 1999 proposed Juvenile pSS criteria, were included. Electronic medical records of pSS from 2013 to 2020 were collected and analyzed. Results 39 patients were included. Of them, 27 (69.2%), 38 (97.4%) and 35 (89.7%) patients fulfilled the AECG criteria, ACR/EULAR criteria and proposal juvenile pSS criteria. The female: male ratio was 3.9:1. Median age at first signs or symptoms and at diagnosis were 9.2 (4.7, 14.5) years and 10.9 (6.3, 15.0) years. The main clinical manifestations were rash or purpura (20, 51.3%), followed by fever (12, 30.8%), glandular enlargement/recurrent parotitis (10, 25.6%), and dry mouth and/or dry eyes (9, 23.1%). 28 (56.4%) patients existed systemic damage, the most common was hematological involvement (14, 35.9%), followed by hepatic (13, 33.3%) and renal involvement (8, 20.5%). 38 (97.4%) patients preformed labial minor salivary gland biopsy, all exhibited focal lymphocytic sialadenitis. All patients had global ESSDAI score ≥ 1 at diagnosis, the median total score at diagnosis was 7 (2, 27). 36 (92.3%) patients followed up at a median time of 23.6 (7.9, 79.5) months, three patients developed systemic lupus erythematosus (SLE) at follow-up time of 13.3, 38.8 and 63.8 months, separately. Conclusions The presentation of childhood-onset pSS is atypical, extraglandular manifestations and systemic involvements were more common. Labial salivary gland biopsy is vital for probable patients. Some patients may develop SLE over time.